Safety and feasibility of intradermal injection with tolerogenic dendritic cells pulsed with proinsulin peptide—for type 1 diabetes
Tatjana Nikolić, Jaap Jan Zwaginga, Bas S. Uitbeijerse, Nicky J. C. Woittiez, Eelco J.P. de Koning, Henk‐Jan Aanstoot, Bart O. Roep
Topics & Concepts
MedicineProinsulinImmune systemImmunologyImmunotherapyAutoimmunityType 1 diabetesDiabetes mellitusType 2 diabetesEndocrinologyDiabetes and associated disordersDiabetes Management and ResearchImmune Cell Function and Interaction